Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

A Study of Gemcitabine/Cisplatin Plus Cemiplimab (REGN2810, Anti-PD-1) With or Without Fianlimab (REGN3767, Anti-LAG-3) in Patients With Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

Phase 2

Not yet recruiting

Conditions: Muscle-Invasive Bladder Carcinoma
Bladder Cancer

Interventions: Drug: Gemcitabine
Drug: Cisplatin
Drug: Cemiplimab
Drug: Fianlimab

First Posted Date: 2024-08-26

Last Posted Date: 2024-08-26

Lead Sponsor: Columbia University

Target Recruit Count: 36

Registration Number: NCT06571708

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

The Sleep2BWell Trial

Not Applicable

Not yet recruiting

Conditions: Diet, Healthy
Weight Loss
Physical Activity
Blood Pressure
Sleep Health

Interventions: Behavioral: Multidimensional Sleep Health Sessions
Behavioral: Healthy Diet Sessions
Behavioral: Physical Activity Sessions

First Posted Date: 2024-08-21

Last Posted Date: 2024-10-30

Lead Sponsor: Columbia University

Target Recruit Count: 210

Registration Number: NCT06565104

Locations: 🇺🇸
Columbia University Irving Medical Center, Mailman School of Public Health, New York, New York, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

Human Models of Selective Insulin Resistance: Pancreatic Clamp

Phase 1

Not yet recruiting

Conditions: Insulin Resistance
Hyperinsulinemia
Metabolic Dysfunction Associated Steatotic Liver Disease
Non-Alcoholic Fatty Liver Disease
Prediabetic State
Obesity

Interventions: Drug: Insulin human
Drug: Octreotide Acetate
Drug: Glucagon
Drug: Growth Hormone, Human
Drug: 20% D-glucose (aq)
Diagnostic Test: [6,6-2H2] D-glucose
Diagnostic Test: [1-13C1] sodium acetate
Dietary Supplement: Nestle BOOST Plus
Dietary Supplement: KIND Bar
Device: Harvard Apparatus PHD ULTRA CP syringe pump
Device: Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer

First Posted Date: 2024-08-16

Last Posted Date: 2024-08-16

Lead Sponsor: Columbia University

Target Recruit Count: 36

Registration Number: NCT06558422

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Effects of tDCS and VNS on Postoperative Analgesia

Not Applicable

Not yet recruiting

Conditions: Acute Postoperative Pain

Interventions: Other: Sham transcranial direct current stimulation
Device: Active transcranial direct current stimulation
Device: Active vagus nerve stimulation
Other: Sham vagus nerve stimulation

First Posted Date: 2024-08-14

Last Posted Date: 2024-08-14

Lead Sponsor: Columbia University

Target Recruit Count: 200

Registration Number: NCT06554067

Medically Tailored Meals for Cardiovascular Health Equity

Not Applicable

Recruiting

Conditions: Diet, Healthy
HbA1c
Blood Pressure

Interventions: Behavioral: Medically Tailored Meals and Nutritional Counseling
Behavioral: Cardiovascular Health Promotion Educational Program

First Posted Date: 2024-08-13

Last Posted Date: 2024-10-16

Lead Sponsor: Columbia University

Target Recruit Count: 200

Registration Number: NCT06550297

Locations: 🇺🇸
Columbia University Mailman School of Public Health, New York, New York, United States

Prediction of Anxiety and Memory State

Recruiting

Conditions: Anxiety
Epilepsy
Memory

Interventions: Other: CAMERA (Context-Aware Multimodal Ecological Research and Assessment)

First Posted Date: 2024-08-13

Last Posted Date: 2024-08-20

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT06551090

Locations: 🇺🇸
Columbia University, New York, New York, United States

Engaging Patients in Adherence Interventions Using Behavioral Science

Not Applicable

Conditions: Uncontrolled Hypertension

Interventions: Behavioral: Control recruitment letter
Behavioral: Primer postcard
Behavioral: Behavioral theory-informed recruitment letter
Behavioral: 4 phone calls
Behavioral: 2 phone calls

First Posted Date: 2024-08-09

Last Posted Date: 2024-11-27

Lead Sponsor: Columbia University

Target Recruit Count: 584

Registration Number: NCT06543394

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus

Phase 1

Recruiting

Conditions: Systemic Lupus Erythematosus

Interventions: Biological: NKX019
Drug: Cyclophosphamide LD

First Posted Date: 2024-07-24

Last Posted Date: 2024-07-24

Lead Sponsor: Columbia University

Target Recruit Count: 6

Registration Number: NCT06518668

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

PiMZ Longitudinal Cohort (PiMZ Logic)

Not yet recruiting

Conditions: Alpha 1-Antitrypsin Deficiency
Emphysema or COPD

First Posted Date: 2024-07-17

Last Posted Date: 2024-12-13

Lead Sponsor: Columbia University

Target Recruit Count: 80

Registration Number: NCT06505603

Locations: 🇺🇸
University of California- Los Angeles, Los Angeles, California, United States
🇺🇸
Columbia University, New York, New York, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

and more 2 locations

Probiotic Chocolate Study in Multiple Sclerosis

Not Applicable

Active, not recruiting

Conditions: Multiple Sclerosis
Healthy Nutrition

Interventions: Dietary Supplement: Bouchard Belgian Dark Chocolate Probiotic Napolitains, containing bifidobacterium longum

First Posted Date: 2024-06-26

Last Posted Date: 2024-11-28

Lead Sponsor: Columbia University

Target Recruit Count: 92

Registration Number: NCT06475183

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy